Lv45
420 积分 2024-09-11 加入
Highlighting recent progress in the treatment of men with advanced prostate cancer
8天前
已完结
PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer
1个月前
已完结
Assessments of prostate cancer cell functions highlight differences between a pan‐PI3K/mTOR inhibitor, gedatolisib, and single‐node inhibitors of the PI3K/AKT/mTOR pathway
1个月前
已完结
PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway
1个月前
已完结
METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3/AKT pathway and synergizes with PARP inhibitor
1个月前
已完结
Phosphatase LHPP confers prostate cancer ferroptosis activation by modulating the AKT-SKP2-ACSL4 pathway
1个月前
已完结
Cuproptosis: Mechanism, role, and advances in urological malignancies
2个月前
已完结
皖公网安备34019202002308
